Cogent Biosciences (COGT)
NASDAQ:COGT
US Market
Holding COGT?
Track your performance easily

Cogent Biosciences (COGT) Income Statement

537 Followers

Cogent Biosciences Income Statement

Last quarter (Q2 2024), Cogent Biosciences's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Cogent Biosciences's net income was $-58.95M. See Cogent Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 950.00K$ 950.00K$ 2.62M$ 2.47M$ 7.87M-
Cost of Revenue
----$ -46.91M-
Gross Profit
$ 950.00K$ 950.00K$ 2.62M$ 2.47M$ 54.78M-
Operating Expense
$ 244.60M$ 208.13M$ 147.84M$ 75.55M$ 43.16M$ 54.68M
Operating Income
$ -244.60M$ -208.13M$ -147.84M$ -75.55M$ -82.20M$ -54.68M
Net Non Operating Interest Income Expense
$ 17.52M$ 13.08M$ 3.99M$ 467.00K$ 144.00K$ 267.00K
Other Income Expense
$ 3.55M$ 2.64M$ 3.61M$ -2.81M$ -7.25M$ -22.58M
Pretax Income
$ -227.04M$ -192.41M$ -140.24M$ -72.27M$ 19.01M$ -31.83M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -227.04M$ -192.41M$ -140.24M$ -72.27M$ -179.21M$ -31.83M
Basic EPS
$ -2.49$ -2.42$ -2.39$ -1.87$ -16.17$ 0.07
Diluted EPS
$ -2.49$ -2.42$ -2.39$ -1.87$ -16.17$ -4.18
Basic Average Shares
$ 367.19M$ 79.66M$ 58.74M$ 38.73M$ 11.08M$ 7.62M
Diluted Average Shares
$ 367.19M$ 79.66M$ 58.74M-$ 11.08M$ 7.62M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 244.60M$ 208.13M$ 147.84M$ 75.55M$ -3.75M$ 54.68M
Net Income From Continuing And Discontinued Operation
$ -227.04M$ -192.41M$ -140.24M$ -72.27M$ -74.81M$ -31.83M
Normalized Income
$ -102.11M-----
Interest Expense
------
EBIT
$ -239.16M$ -208.13M$ -147.84M$ -75.55M$ -35.29M$ -31.83M
EBITDA
$ -233.97M$ -204.54M$ -141.96M$ -73.56M$ -34.57M$ -30.59M
Currency in USD

Cogent Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis